Results 71 to 80 of about 2,070,589 (168)

17 Beta-oestradiol attenuates dexamethasone-induced lethal and sublethal neuronal damage in the striatum and hippocampus

open access: yes, 2003
Abnormal corticosteroid release is extensively associated with mood disorders. This association may result from the toxic actions of endogenous corticosteroids which can induce apoptosis of hippocampal neurons.
Mitchell, Ian   +3 more
core   +1 more source

Early Switch to Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema Poorly Responding to Anti-VEGF Therapy: A Narrative Review

open access: yesOphthalmology and Therapy
Diabetic macular edema (DME) is a potential complication of diabetic retinopathy (DR) and a leading cause of DR-related impairment of central vision. The pathogenesis of DME is complex and multifactorial.
Riccardo Sacconi   +8 more
doaj   +1 more source

Chronic Antidepressant Medication Attenuates Dexamethasone Induced Neuronal Death and Sub-lethal Neuronal Damage in the Hippocampus and Striatum

open access: yes, 2004
Dexamethasone, a synthetic corticosteroid, which can induce a range of mood disorders including depression and affective psychosis, is toxic to specific hippocampal and striatal neuronal populations.
Mitchell, Ian   +5 more
core   +1 more source

Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study

open access: yesSAGE Open Medicine
Objectives: To determine the optimal initial insulin dosage for controlling hyperglycemia in COVID-19 patients receiving steroids, an area with limited data.
Nuttavadee Ketaroonrut   +2 more
doaj   +1 more source

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

open access: yes, 2022
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 ...
T Benfield (12435408)   +45 more
core  

Bioactivity of dexamethasone-releasing coatings on polymer/magnesium composites

open access: yes, 2016
We developed biodegradable polymeric coatings loaded with increasing amounts of dexamethasone on composites based on polylactic acid and Mg particles for bone repair.
González-Carrasco, José Luis   +12 more
core   +1 more source

RELATIONSHIP BETWEEN THE IN SILICO AND IN VIVO ANTIDIABETIC AND ANTIATHEROSCLEROTIC PROPERTIES OF NOVEL DIHYDROPYRIDINE AND THIENOPYRIDINE DERIVATIVES

open access: yesПаёми Сино
Objective: To evaluate the relationship between the in silico and in vivo antidiabetic and antiatherosclerotic properties of novel dihydropyridine and thienopyridine derivatives using an experimental model of combined dietary loading followed by ...
Bibik Elena Yurievna   +2 more
doaj   +1 more source

The Efficacy of Dexamethasone in the Prevention of Postoperative Shivering: A Double-blind Placebo-Controlled Clinical Trial [PDF]

open access: yes
Background: Post-operative shivering is very common and followed by many problems such as increasing oxygen consumption, blood pressure, intracranial and intraocular pressure, and post-operation pain.
عیسی زاده فر, خاطره   +1 more
core  

Effect of intravenous dexamethasone in dimishing alfentanyl-induced-cough [PDF]

open access: yes
Background & objectives: The use of synthetic opioids (fentanil, alfentanil, …) has been increasing as they can induce anesthesia without histamine release to the stress caused by anesthesia and can cause an effective analgesia at first cut.
نوروزی, ودود   +1 more
core  

Clinical and pharmacological determinants of serum dexamethasone concentrations during 1-mg DST

open access: yes
Context: The 1-mg overnight dexamethasone suppression test (1-mg DST) is widely used to screen for hypercortisolism, but its interpretation may be affected by variability in dexamethasone exposure due to clinical and pharmacological factors. Objective:
Ceccato, Filippo
core   +1 more source

Home - About - Disclaimer - Privacy